FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ertapenem (ertapenem sodium) filed by ENDO USA, Inc. This action updates regulatory status for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Gynecologic Infection
• Intra-abdominal Infection
• Skin and Skin Structure Infection

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

SUPPL AP for ERTAPENEM (ERTAPENEM SODIUM)